A group of Miller School scientists has received a $1.6 million small business award from the National Institute of Neurological Disorders and Stroke, a unit of the National Institutes of Health, to support development and clinical trials of a novel anti-inflammatory antibody treatment for human spinal cord injury.
Advancements In Parkinson's TreatmentVisit Page >>
Back pain? Visit the Spine Institute.Get Started
What do our patients have to say?Find Out
More than 50 years of innovative care.Learn More
Miller School scientists will join researchers from more than 20 other institutions in the International Traumatic Brain Injury Initiative, a five-year international research project on concussion and traumatic brain injury funded by an $18.8 million grant from the National Institutes of Health.